2022 / 04

DOI: 10.24075/medet.2022.064
Copyright: © 2023 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Ethical aspects of phytotherapy

Korotaeva MS, Sidorov AV, Tichonova IG
About authors

Yaroslavl State Medical University, Yaroslavl, Russia

Correspondence should be addressed: Marina S. Korotaeva
Octyabr avenue, 17D, Yaroslavl, 150040, Russia; ur.relbmar@aveatorokm

About paper

Author contribution: Korotaeva MS — data analysis, manuscript preparation; Sidorov AV — concept of publication, editing; Tichonova IG — data selection.

Received: 2022-10-22 Accepted: 2022-11-24 Published online: 2023-01-30
|
  1. Wills RB, Bone K, Morgan M. Herbal products: active constituents, modes of action and quality control. Nutr Res Rev. 2000; 13 (1): 47–77.
  2. Shih EV, Bulaev VM, Demidova OA. Problemy ocenki bezopasnosti lekarstvennyh rastenij. Bezopasnost’ i risk farmakoterapii. 2015; 2: 23–29. Russian.
  3. Boullata JI, Nace AM. Safety Issues with Herbal Medicine. Pharmacotherapy. 2000; 20 (3): 257–269.
  4. Samylina IA, Bulaev VM. Problemy bezopasnosti lekarstvennyh rastenij, soderzhashchih endogennye toksichnye veshchestva. Farmaciya. 2009; 3: 6–8. Russian.
  5. Barnes J, Anderson L, Phillipson J. Herbal medicines. London, Chicago: Pharmaceutical Press. 2007; 721 p.
  6. Privalova EG, Mirovich VI. Osnovy fitotoksikologii. Obzor rastitel’nyh ob”ektov. Elementy fitohimicheskogo analiza. Irkutsk: IGMU. 2018; 102 s. Russian.
  7. Bulaev VM, Shih EV, Sychev DA. Bezopasnost’ i effektivnost’ lekarstvennyh rastenij. M.: Prakticheskaya medicina. 2013; 272 s. Russian.
  8. SHih EV, Bulaev VM, Demidova OA, Krutikova NM, Sokova EA. Bezopasnost’ primeneniya lekarstvennyh rastitel’nyh preparatov: lekarstvennye rasteniya s gormonal’noj aktivnost’yu. Vedomosti Nauchnogo centra ekspertizy sredstv medicinskogo primeneniya. 2013; 3: 49–52. Russian.
  9. Chadwick LR, Pauli GF, Farnsworth NR. The pharmacology Humulus lupulus L. (hops) with an emphasis of properties. Phytomedicine. 2006; 13: 119–131.
  10. Cos P, De Bruyne T, Apers S, et al. Phytoestrogens: recent developments. Planta Med. 2003; 69 (7): 589–599.
  11. Tutel’yan VA, Belousov YuB, Gurevich KG. Bezopasnost’ i effektivnost’ biologicheski aktivnyh veshchestv rastitel’nogo proiskhozhdeniya. Novosibirsk: EKOR-KNIGA. 2007; 316 s. Russian.
  12. Heyerick A, Vervarcke S, Depypere H, et al. A first prospective, randomized, doubleblind, placebo controlled stady on the use of standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006; 54 (2): 164–175.
  13. Tarlovskaya EI, Koziolova NA, CHesnikova AI. Vliyanie obraza zhizni na effektivnost’ i bezopasnost’ lekarstvennyh preparatov v kardiologicheskoj praktike: chto dolzhen uchityvat’ vrach? Rossijskij kardiologicheskij zhurnal. 2016; 1: 51–59. Russian.
  14. Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions. Front Pharmacol. 2012; 3: 69.
  15. Kirilyuk AA, Petrishche TL. Osobennosti vliyaniya biologicheski aktivnyh veshchestv lekarstvennyh rastenij na farmakologicheskuyu aktivnost’ lekarstvennyh sredstv. Sovremennye problemy zdravoohraneniya i medicinskoj statistiki. 2017; 2. Russian.
  16. Gribakina OG, Kolyvanov GB, Litvin AA, et al. Farmakokineticheskie vzaimodejstviya lekarstvennyh veshchestv, metaboliziruemyh izofermentom citohroma P450 CYP2C9. Farmakokinetika i farmakodinamika. 2016; 1: 21–32. Russian.
  17. Komoroski BJ, Zhang S, Cai H, et al. Induction and inhibition of cytochromes P450 by the St. John’s wort constituent hyperforin in human hepatocyte cultures. Drug Metabolism and Disposition. 2004; 32 (5): 512–518.
  18. Wang Z, Gorski JC, Hamman MA, et al. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther. 2001; 70 (4): 317–326.
  19. Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004; 75 (1): 89–100.
  20. Solhaug V, Molden E. Individual variability in clinical effect and tolerability of opioid analgesics — Importance of drug interactions and pharmacogenetics Scandinavian Journal of Pain. 2017; 17 (1): 193–200.
  21. Johne A, Schmider J, Brockmöller J, et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John’s wort (Hypericum perforatum). J Clin Psychopharmacol. 2002; 22: 46–54.